Alps Advisors Inc Vericel Corp Transaction History

Alps Advisors Inc

  • $17.8 Billion
  • Q3 2025

A detailed history of Alps Advisors Inc transactions in Vericel Corp stock. As of the latest transaction made, Alps Advisors Inc holds 22,857 shares of VCEL stock, worth $911,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,857
Previous 27,145 15.8%
Holding current value
$911,080
Previous $1.16 Million 37.75%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025
SELL
$29.84 - $41.74 $127,953 - $178,981
-4,288 Reduced 15.8%
22,857 $719,000
Q2 2025

Aug 11, 2025
SELL
$37.92 - $45.7 $340,369 - $410,203
-8,976 Reduced 24.85%
27,145 $1.16 Million
Q1 2025

Apr 30, 2025
SELL
$44.5 - $61.8 $168,655 - $234,222
-3,790 Reduced 9.5%
36,121 $1.61 Million
Q4 2024

Feb 13, 2025
BUY
$40.05 - $59.11 $113,101 - $166,926
2,824 Added 7.61%
39,911 $2.19 Million
Q3 2024

Nov 12, 2024
SELL
$42.25 - $53.56 $34,560 - $43,812
-818 Reduced 2.16%
37,087 $1.57 Million
Q2 2024

Aug 13, 2024
BUY
$41.71 - $52.9 $160,208 - $203,188
3,841 Added 11.28%
37,905 $1.74 Million
Q1 2024

May 14, 2024
BUY
$32.52 - $52.33 $49,235 - $79,227
1,514 Added 4.65%
34,064 $1.77 Million
Q4 2023

Feb 14, 2024
SELL
$30.85 - $37.09 $81,320 - $97,769
-2,636 Reduced 7.49%
32,550 $1.16 Million
Q3 2023

Nov 14, 2023
BUY
$31.69 - $39.25 $7,130 - $8,831
225 Added 0.64%
35,186 $1.18 Million
Q2 2023

Aug 14, 2023
BUY
$29.0 - $38.37 $108,924 - $144,117
3,756 Added 12.04%
34,961 $1.31 Million
Q1 2023

May 10, 2023
SELL
$23.85 - $31.34 $19,199 - $25,228
-805 Reduced 2.51%
31,205 $914,000
Q4 2022

Feb 14, 2023
BUY
$17.65 - $27.37 $110,259 - $170,980
6,247 Added 24.25%
32,010 $843,000
Q3 2022

Nov 14, 2022
SELL
$22.62 - $32.54 $49,583 - $71,327
-2,192 Reduced 7.84%
25,763 $598,000
Q2 2022

Aug 11, 2022
BUY
$22.88 - $39.45 $639,610 - $1.1 Million
27,955 New
27,955 $704,000
Q4 2021

Feb 09, 2022
SELL
$35.2 - $52.6 $2.01 Million - $3.01 Million
-57,152 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$46.35 - $59.75 $167,045 - $215,339
-3,604 Reduced 5.93%
57,152 $2.79 Million
Q2 2021

Aug 11, 2021
SELL
$47.2 - $67.81 $1.06 Million - $1.52 Million
-22,387 Reduced 26.93%
60,756 $3.19 Million
Q1 2021

May 07, 2021
BUY
$30.93 - $59.48 $41,848 - $80,476
1,353 Added 1.65%
83,143 $4.62 Million
Q4 2020

Feb 03, 2021
BUY
$18.53 - $31.5 $446,369 - $758,803
24,089 Added 41.75%
81,790 $2.53 Million
Q3 2020

Nov 04, 2020
SELL
$14.68 - $19.12 $53,420 - $69,577
-3,639 Reduced 5.93%
57,701 $1.07 Million
Q2 2020

Aug 05, 2020
SELL
$8.5 - $15.82 $169,269 - $315,039
-19,914 Reduced 24.51%
61,340 $848,000
Q1 2020

May 06, 2020
SELL
$7.25 - $19.22 $68,715 - $182,167
-9,478 Reduced 10.45%
81,254 $745,000
Q4 2019

Feb 07, 2020
BUY
$13.77 - $19.2 $37,123 - $51,763
2,696 Added 3.06%
90,732 $1.58 Million
Q3 2019

Nov 04, 2019
SELL
$14.93 - $19.83 $57,749 - $76,702
-3,868 Reduced 4.21%
88,036 $1.33 Million
Q2 2019

Aug 07, 2019
SELL
$15.01 - $18.89 $192,052 - $241,697
-12,795 Reduced 12.22%
91,904 $1.74 Million
Q1 2019

May 01, 2019
BUY
$16.23 - $20.29 $73,359 - $91,710
4,520 Added 4.51%
104,699 $1.83 Million
Q4 2018

Feb 04, 2019
BUY
$10.77 - $18.44 $264,629 - $453,089
24,571 Added 32.5%
100,179 $1.74 Million
Q3 2018

Oct 25, 2018
BUY
$9.1 - $14.8 $139,821 - $227,402
15,365 Added 25.51%
75,608 $1.07 Million
Q2 2018

Aug 02, 2018
BUY
$9.6 - $14.6 $578,332 - $879,547
60,243 New
60,243 $584,000

Others Institutions Holding VCEL

# of Institutions
274
Shares Held
52.6M
Call Options Held
36.6K
Put Options Held
9.1K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.88B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email